Since the MGMT promoter is known as a prognostic biomarker for alkylating chemotherapy in glioblastoma patients, the study also investigated an association between the use of cisplatin and MGMT promoter methylation; however, there was no significant association. The gene discussed is MGMT; the disease is glioblastoma.